The Journal of Immunology, Vol 155, Issue 10 4757-4765, Copyright © 1995 by American Association of Immunologists

ARTICLES

Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR

AB Vogt, LJ Stern, C Amshoff, B Dobberstein, GJ Hammerling and H Kropshofer
German Cancer Research Center, Tumorimmunology Program, Heidelberg, Germany.

In the endoplasmic reticulum, MHC class II alpha beta dimers associate with the trimeric invariant chain (li), generating a nine-subunit (alpha beta li)3 complex. In the presence of li, the peptide binding groove is blocked, so that loading with self or antigenic peptides can only occur after proteolytic removal of li in specialized post-Golgi compartments. The class II-associated invariant chain peptide region of li (about residues 81-104) is known to mediate binding to class II molecules and blockade of the groove, but this does not exclude additional contact sites for li. Using a set of overlapping li peptides and recombinant soluble li, we demonstrate here that a large segment of li encompassing approximately residues 71 to 128 interacts with HLA-DR molecules. The N- and C-terminal regions of this li segment appear to bind outside the peptide groove to the contact area for the staphylococcal superantigen Staphylococcus aureus enterotoxin B on the alpha 1 domain. The core region of this segment (residues 95-108) prevents binding of antigenic peptides, probably by interaction with the peptide groove. Occupation of the groove with antigenic peptides abolishes binding not only of the core region, but also that of those li peptides that bind outside the groove. These findings suggest the existence of distinct conformational states of class II molecules, with li binding preferentially to one form.

This article has been cited by other articles:

				G. A. Azar, R.-P. Sekaly, and J. Thibodeau A Defective Viral Superantigen-Presenting Phenotype in HLA-DR Transfectants Is Corrected by CIITA J. Immunol., June 15, 2005; 174(12): 7548 - 7557. [Abstract] [Full Text] [PDF]

				C. H. Koonce, G. Wutz, E. J. Robertson, A. B. Vogt, H. Kropshofer, and E. K. Bikoff DM Loss in k Haplotype Mice Reveals Isotype-Specific Chaperone Requirements J. Immunol., April 1, 2003; 170(7): 3751 - 3761. [Abstract] [Full Text] [PDF]

				M. W. Hofmann, S. Honing, D. Rodionov, B. Dobberstein, K. von Figura, and O. Bakke The Leucine-based Sorting Motifs in the Cytoplasmic Domain of the Invariant Chain Are Recognized by the Clathrin Adaptors AP1 and AP2 and their Medium Chains J. Biol. Chem., December 17, 1999; 274(51): 36153 - 36158. [Abstract] [Full Text] [PDF]

				J. B. Ashman and J. Miller A Role for the Transmembrane Domain in the Trimerization of the MHC Class II-Associated Invariant Chain J. Immunol., September 1, 1999; 163(5): 2704 - 2712. [Abstract] [Full Text] [PDF]

				W. Chen, C. Thoburn, and A. D. Hess Characterization of the Pathogenic Autoreactive T Cells in Cyclosporine-Induced Syngeneic Graft-Versus-Host Disease J. Immunol., December 15, 1998; 161(12): 7040 - 7046. [Abstract] [Full Text] [PDF]

				N. A. Wilson, P. Wolf, H. Ploegh, L. Ignatowicz, J. Kappler, and P. Marrack Invariant Chain Can Bind MHC Class II at a Site Other Than the Peptide Binding Groove J. Immunol., November 1, 1998; 161(9): 4777 - 4784. [Abstract] [Full Text] [PDF]

				I. M. Siebenkotten, C. Carstens, and N. Koch Identification of a Sequence That Mediates Promiscuous Binding of Invariant Chain to MHC Class II Allotypes J. Immunol., April 1, 1998; 160(7): 3355 - 3362. [Abstract] [Full Text] [PDF]